A carregar...
SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy
Introduction: Immune related endocrine adverse effects (IReAs) caused by checkpoint inhibitors (CI) used in the treatment of advanced cancers are rare and often under recognized, but they can be potentially life-threatening. Case: A 69 y/o male with stage 4 metastatic colon cancer was evaluated 10 d...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552853/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-413 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|